Figure 5. Non-relapse mortality from time of initiation of acute GVHD treatment.
“False-positive” line represents patients with an albumin decrease of ≥0.5 g/dL, but who did not progress to grade 3/4 acute GVHD. Non-relapse mortality is increased only in patients with an albumin decrease and severe acute GVHD, suggesting that the prognostic value of albumin decrease is linked entirely to its ability to predict severe acute GVHD.